381![Microsoft Word - EPO Letter Final[removed]doc Microsoft Word - EPO Letter Final[removed]doc](https://www.pdfsearch.io/img/b6df22190828fa6a7b9d0b143e7f3d28.jpg) | Add to Reading ListSource URL: www.amgen.comLanguage: English - Date: 2013-10-01 12:19:56
|
---|
382![Microsoft Word - SNF Round 2 Faxblast[removed]DRAFTv3.doc Microsoft Word - SNF Round 2 Faxblast[removed]DRAFTv3.doc](https://www.pdfsearch.io/img/0bc40b676e4b057b798a3f14d3ddf813.jpg) | Add to Reading ListSource URL: www.amgen.comLanguage: English - Date: 2013-10-01 12:20:21
|
---|
383![Certificate of Separation Amgen is committed to complying with Independent Medical Education (“IME”) accreditation requirements that IME content remain separate and independent from undue influence of the commercial Certificate of Separation Amgen is committed to complying with Independent Medical Education (“IME”) accreditation requirements that IME content remain separate and independent from undue influence of the commercial](https://www.pdfsearch.io/img/22bc93802d7f30ab43c60c387ef5e502.jpg) | Add to Reading ListSource URL: www.amgen.comLanguage: English - Date: 2014-01-03 14:08:26
|
---|
384![Microsoft Word - Form A - Sponsor Enrollment Form-blankv2[removed]doc Microsoft Word - Form A - Sponsor Enrollment Form-blankv2[removed]doc](https://www.pdfsearch.io/img/badb31b6a753bd0d74342e0a17e8c065.jpg) | Add to Reading ListSource URL: www.amgen.comLanguage: English - Date: 2013-10-01 12:19:59
|
---|
385![MEDICATION GUIDE PROCRIT® (PROKRIT) (epoetin alfa) Read this Medication Guide: before you start PROCRIT. if you are told by your healthcare provider that there is new information about PROCRIT. MEDICATION GUIDE PROCRIT® (PROKRIT) (epoetin alfa) Read this Medication Guide: before you start PROCRIT. if you are told by your healthcare provider that there is new information about PROCRIT.](https://www.pdfsearch.io/img/c1aa9f724767307dee66e532bcc01a4e.jpg) | Add to Reading ListSource URL: www.procrit.comLanguage: English - Date: 2014-01-07 15:29:47
|
---|
386![Non-Cash Donation Form Date last updated: [removed]Qualifications: This program is currently applicable to North America and Puerto Rico only; Health Care Providers are not eligible to participate in the program. Non-Cash Donation Form Date last updated: [removed]Qualifications: This program is currently applicable to North America and Puerto Rico only; Health Care Providers are not eligible to participate in the program.](https://www.pdfsearch.io/img/687ff25cc73f61360ddb265d0ee4d5a2.jpg) | Add to Reading ListSource URL: www.amgen.comLanguage: English - Date: 2013-10-01 12:19:16
|
---|
387![NEUPOGEN® (filgrastim) DESCRIPTION Filgrastim is a human granulocyte colony-stimulating factor (G-CSF)‚ produced by ® recombinant DNA technology. NEUPOGEN is the Amgen Inc. trademark for filgrastim‚ which has been NEUPOGEN® (filgrastim) DESCRIPTION Filgrastim is a human granulocyte colony-stimulating factor (G-CSF)‚ produced by ® recombinant DNA technology. NEUPOGEN is the Amgen Inc. trademark for filgrastim‚ which has been](https://www.pdfsearch.io/img/07d49712a6829cae164ed2788c650e58.jpg) | Add to Reading ListSource URL: patentdocs.typepad.comLanguage: English - Date: 2014-07-29 01:16:49
|
---|
388![Microsoft Word - DLPReview.doc Microsoft Word - DLPReview.doc](https://www.pdfsearch.io/img/d894f7f335ff4d77942495af58e7acd6.jpg) | Add to Reading ListSource URL: www.ipo.gov.ukLanguage: English - Date: 2009-01-05 07:26:46
|
---|
389![Patent Inter-Partes Decision O[removed] Patent Inter-Partes Decision O[removed]](https://www.pdfsearch.io/img/65dee67a1d658b3d30be39ac82357432.jpg) | Add to Reading ListSource URL: www.ipo.gov.ukLanguage: English - Date: 2007-07-09 09:18:30
|
---|
390![Microsoft Word - Form A - Sponsor Enrollment Form-blankv2[removed]_2_.doc Microsoft Word - Form A - Sponsor Enrollment Form-blankv2[removed]_2_.doc](https://www.pdfsearch.io/img/145ce835a25f45f3b9cc196d93b535d7.jpg) | Add to Reading ListSource URL: www.amgen.comLanguage: English - Date: 2013-10-01 12:20:20
|
---|